Astal Laboratories Ltd Financials
Company Logo

Astal Laboratories Ltd Financial Statement

Astal Laboratories Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue23.50
Operating Expense19.28
Net Profit2.74
Net Profit Margin11.66
Earning Per Share2.80
EBIDTA4.22
Effective Tax Rate26.30

Astal Laboratories Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual23.65
Operating Expenses Annual22.53
Operating Profit Annual1.13
Interest Annual0.01
Depreciation0.03
Net Profit Annual0.78
Tax Annual0.30

Astal Laboratories Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.08
Cash Flow from Operations-5.59
Cash Flow from Investing-6.11
Cash Flow from Financing17.69
Cash Flow at the End6.08

Astal Laboratories Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)4.78
PBIT Margin (%)4.65
PBT Margin (%)-456.24
Net PROFIT Margin (%)3.30
Return On Networth / Equity (%)5.47
Return On Networth /Employed (%)7.56
Return On Assets (%)5.41
Total Debt / Equity (X)0.01
Asset Turnover Ratio (%)1.64

Astal Laboratories Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.69
Total Current Assets Annual26.73
Non Current Assets Annual9.89
Total Shareholders Funds Annual23.34
Total Assets Annual36.61

Astal Laboratories Ltd Earning Calls

No Data Availabe

FAQS on Astal Laboratories Ltd Financials

As of Jun 4, 2025, Astal Laboratories Ltd has a market capitalization of 134.08 Cr. Value Research classifies it as a Micro-Cap company.

Yes, Astal Laboratories Ltd is with a debt-to-equity ratio of 0.37.

In FY 2024 , Astal Laboratories Ltd recorded a total revenue of approximately 64.23 Cr marking a significant milestone in the company's financial performance.

Astal Laboratories Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 1.2% and 1.5% annually, respectively..

Astal Laboratories Ltd's current PE ratio is 15.01.

Astal Laboratories Ltd's ROCE averaged 10.3% from the FY ending March 2023 to 2025, with a median of 4.6%. It peaked at 25.7% in March 2025, reflecting strong capital efficiency over the period..

Astal Laboratories Ltd's latest EBIT is Rs. 12.68 Cr, surpassing the average EBIT of Rs. 4.60 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions